Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage II Kidney Cancer”

744 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 744 results

Testing effectiveness (Phase 2)Looking for participantsNCT04724018
What this trial is testing

Sacituzumab Govitecan Plus EV in Metastatic UC

Who this might be right for
Urothelial CancerMetastatic Urothelial CarcinomaMetastatic Urothelial Carcinoma of the Renal Pelvis and Ureter+1 more
Dana-Farber Cancer Institute 106
Not applicableStudy completedNCT01550393
What this trial is testing

Biomarkers in Urine Samples From Patients With Wilms Tumor

Who this might be right for
Kidney Cancer
Children's Oncology Group 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT05363631
What this trial is testing

Seleno-L Methionine (SLM)-Axitinib-Pembrolizumab

Who this might be right for
Clear Cell Renal Cell CarcinomaClear Cell Renal Cell Carcinoma Metastatic
Mohammed Milhem 55
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06783348
What this trial is testing

Radiopharmaceutical Treatment of Advanced Kidney Cancer

Who this might be right for
Metastatic Clear Cell Renal Cell Carcinoma
European Organisation for Research and Treatment of Cancer - EORTC 48
Testing effectiveness (Phase 2)Study completedNCT00664326
What this trial is testing

A Phase II Uncontrolled Study of BAY73-4506 in Previously Untreated Patients With Metastatic or Unresectable RCC

Who this might be right for
Carcinoma, Renal Cell
Bayer 49
Testing effectiveness (Phase 2)Active Not RecruitingNCT06390826
What this trial is testing

Testing Sunitinib as Potentially Targeted Treatment in Cancers With cKIT Genetic Changes (MATCH - Subprotocol V)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmRefractory Lymphoma+2 more
National Cancer Institute (NCI) 10
Large-scale testing (Phase 3)UnknownNCT00047138
What this trial is testing

Chemotherapy Before and After Surgery in Treating Children With Wilm's Tumor

Who this might be right for
Kidney Cancer
University of Leicester 350
Early research (Phase 1)Study completedNCT01522820
What this trial is testing

Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors

Who this might be right for
Anaplastic AstrocytomaAnaplastic OligoastrocytomaAnaplastic Oligodendroglioma+62 more
Roswell Park Cancer Institute 18
Testing effectiveness (Phase 2)Study completedNCT00017329
What this trial is testing

PS-341 in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)UnknownNCT02072044
What this trial is testing

Phase II Study of Anlotinib in Patients With Advanced Renal Cell Carcinoma That Have Failed Or Are Intolerant To TKIs Therapy

Who this might be right for
Renal Cell Carcinoma
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 60
Testing effectiveness (Phase 2)Study completedNCT00688753
What this trial is testing

RAPTOR: RAD001 as Monotherapy in the Treatment of Advanced Papillary Renal Cell Tumors Program in Europe

Who this might be right for
CarcinomaRenal CellNon Clear Cell Renal Carcinoma+2 more
Novartis Pharmaceuticals 92
Testing effectiveness (Phase 2)Study completedNCT00126594
What this trial is testing

Sorafenib Tosylate With or Without Recombinant Interferon Alfa-2b in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaRecurrent Renal Cell CarcinomaStage IV Renal Cell Cancer
National Cancer Institute (NCI) 80
Testing effectiveness (Phase 2)Active Not RecruitingNCT04387500
What this trial is testing

Sintilimab Injection Combined With Inlyta in Fumarate Hydratase- Deficient Renal Cell Carcinoma

Who this might be right for
Carcinoma, Renal CellFumarate Hydratase DeficiencyImmunotherapy
West China Hospital 41
Testing effectiveness (Phase 2)UnknownNCT03177239
What this trial is testing

Phase II Sequential Treatment Trial of Single Agent Nivolumab, Then Combination Ipilimumab + Nivolumab in Metastatic or Unresectable Non-Clear Cell Renal Cell Carcinoma (ANZUP1602)

Who this might be right for
Renal Cell CarcinomaPapillary Renal Cell Carcinoma Type 1Papillary Renal Cell Carcinoma Type 2+3 more
Australian and New Zealand Urogenital and Prostate Cancer Trials Group 85
Testing effectiveness (Phase 2)Study completedNCT00550277
What this trial is testing

LBH589 Treatment for Refractory Clear Cell Renal Carcinoma

Who this might be right for
Renal Cell Carcinoma
SCRI Development Innovations, LLC 20
Testing effectiveness (Phase 2)Study completedNCT00005056
What this trial is testing

Bryostatin 1 In Treating Patients With Progressive Kidney Cancer

Who this might be right for
Kidney Cancer
Cancer Research UK
Testing effectiveness (Phase 2)Active Not RecruitingNCT02306954
What this trial is testing

Study of High Dose Interleukin-2 (IL-2) and Stereotactic Body Radiation (SBRT) in Patients With Metastatic Renal Cancer

Who this might be right for
Renal Cell Carcinoma
Providence Health & Services 84
Testing effectiveness (Phase 2)Study completedNCT01090466
What this trial is testing

Gemcitabine Hydrochloride, Cisplatin, and Temsirolimus as First-Line Therapy in Treating Patients With Locally Advanced and/or Metastatic Transitional Cell Cancer of the Urothelium

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
Cardiff University 15
Testing effectiveness (Phase 2)Temporarily pausedNCT06059014
What this trial is testing

Phase I/II Study Evaluating PSMA Targeted Radionuclide Therapy in Adult Patients with Metastatic Clear Cell Renal Cancer

Who this might be right for
Metastatic Clear Cell Renal Cell Carcinoma
Centre Leon Berard 48
Testing effectiveness (Phase 2)UnknownNCT02880943
What this trial is testing

Dose-finding, Safety and Efficacy Study of Radium-223 Dichloride (XOFIGO) in RCC Patients With Bone Metastases. (EIFFEL)

Who this might be right for
Clear-cell Metastatic Renal Cell CarcinomaBone Metastases
Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie 42
Load More Results